Font Size: a A A

Comparision Of Surgical Complication Rate Between Laparoscopic And Open Radical Resection For Mid-Low Rectal Cancer Following Neoadjuvant Chemoradiotherapy

Posted on:2012-11-27Degree:MasterType:Thesis
Country:ChinaCandidate:G Y ZhangFull Text:PDF
GTID:2154330335477327Subject:Surgery
Abstract/Summary:PDF Full Text Request
Purpose: To compare the surgical complication rate between laparoscopic and open radical resection for mid-low rectal cancer following neoadjuvant chemoradiotherapy (NeoCRT).Methods:A retrospective analysis was conducted among 65 patients with locally advanced mid-low rectal cancer (Clinical staging:T34,N0M0 and T14,N1-2M0who received neoadjuvant chemoradiotherapy from March 2003 to August 2010. Among them 5 cases who were converted to open surgery were removed, thirty-two cases received laparoscopic total mesorectal excision (TME) after neoadjuvant chemoradiotherapy (laparoscopic group, LP group) and twenty-eight cases received open operation (open group, OP group). The clinical data and surgical data of the two groups of patients were compared.Results: The two groups were comparable in the operative time, lymph node yield, positive surgical margins, and occurrence of intra-operative complications. The intra-operative blood loss, intestinal function recovery, days of postoperative hospitalization etc. is significantly better in LP group than that in OP group. The intra-operative complication rate was 3.1% in LP group and 3.6% in OP group(χ2=0.009; P>0.05). The overall postoperative complication rate was 12.5% in LP group and 35.7% in OP group(χ2=4.499; P<0.05),among which the complication rate of post-operative intestinal obstruction was 3.1% in LP group and 10.7% in OP group(χ2=0.382; P>0.05 ) ,when that of stoma leak was 13.3% and 16.7%(χ2=0.059;P>0.05)and that of pulmonary infection was 3.1% and 10.7%(χ2=1.382; P>0.05).There is incision infection in two cases in OP group.Conclusion:Laparoscopic radical resection for mid-low rectal cancer following neoadjuvant chemoradiotherapy can reduce intra-operative blood loss, promote the recovery of intestinal function and decrease days of postoperative hospitalization compare to open radical resection for mid-low rectal cancer following neoadjuvant chemoradiotherapy. There is no difference in intra-operative complication rate between LP and OP groups, but the post-operative complication rate is significantly lower in LP group than that in OP group.
Keywords/Search Tags:Rectal cancer, Neoadjuvant chemoradiotherapy, Laparoscopy, complication
PDF Full Text Request
Related items
1.The Prognostic Significance Of The Treatment Response Of Regional Lymph Nodes And The Refinement Of Current TNM Staging System In Locally Advanced Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy 2.The Safety And Efficacy Of Radical Surgery Fo
Comparison Of Efficacy Between Laparoscopic And Open Radical Resection For Mid Or Low Rectal Cancer Following Neoadjuvant Chemoradiotherapy
Clinical Efficacy Of Neoadjuvant Chemoradiotherapy In Middle And Low Rectal Cancer With C?-c? Stage And The Effect Of NCRT On The Expression Of VEGF In Rectal Cancer
Effect Of Neoadjuvant Radiotherapy And Chemotherapy On Postoperative Complications And Short-term And Long-term Efficacy Of Laparoscopic-assisted Rectal Cancer
Locally Advanced Rectal Cancer Neoadjuvant Chemoradiotherapy Complication After Operation And Pathological Response Analysis
The Safety And Efficacy Of Laparoscopic Surgery And Open Surgery In Treatment Of Mid-low Rectal Cancer After Neoadjuvant Chemoradiotherapy: A Meta-analysis
Comparative Study Of Neoadjuvant Chemotherapy And Neoadjuvant Chemoradiotherapy Clinical Efficacy On Mid-set And Low-set Locally Advanced Rectal Cancer
PART 1:the Prognostic Value Of Tumor Deposits In Rectal Cancer With Neoadjuvant Chemo Radiotherapy PART2:The Propensity Score-matched Analysis Of Metastasis Pattern And The Predictive Model For Distant Metastasis For Locally Advanced Rectal Cancer After N
Long-Term Outcomes In Patients With YpTO Rectal Cancer After Neoadjuvant Chemoradiotherapy And Curative Resection
10 Clinical Application And Curative Efficacy Analysis Of Neoadjuvant Chemoradiotherapy In Patients With Stage Ⅱ And Ⅲ Middle And Lower Rectal Cancer